Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Myriad Uranium Closes Over-Subscribed Private Placement

In This Article:

Vancouver, British Columbia--(Newsfile Corp. - December 13, 2024) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement financing (the "Financing") (see Myriad's news release dated November 22, 2024). Under the over-subscribed Financing, Myriad raised gross proceeds of $2,988,600 through the issuance of 7,471,500 units (each, a "Unit") at a price of $0.40 per Unit. Each Unit is comprised of one common share of the Company (each, a "Share") and one-half of one common share purchase warrant (each full warrant, a "Warrant"), with each Warrant entitling the holder to purchase one Share at an exercise price of $0.55 per Share until December 12, 2026.

Myriad's CEO, Thomas Lamb, commented, "This oversubscribed financing is the culmination of a highly successful year for the Company with a drill program that exceeded expectations, verified historical data, and also showcased the potential for deeper uranium mineralization. The funds will enable continued momentum throughout the winter as we lock up all key areas around the project, conduct additional geophysics, and position ourselves for an ambitious 2025 drill program."

In connection with the Financing, the Company paid aggregate finder's fees of $68,320 and issued an aggregate of 170,800 finder's warrants (each, a "Finder's Warrant"), each Finder's Warrant exercisable for one Share at a price of $0.40 until December 12 2026. Securities issued under the Financing are subject to a four month hold period expiring April 13, 2025, in accordance with applicable Canadian securities laws. The Company intends to use the proceeds of the Financing for exploration of the Company's mineral properties and for general working capital.

Directors and officers of the Company participated in the Financing, and such participation is considered to be a "related party transaction" as defined under Multilateral Instrument 61-101 ("MI 61-101"). This participation is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of such participation does not exceed 25% of the market capitalization of the Company, as determined in accordance with MI 61-101.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States. Such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or "U.S. Persons", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.